Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dimethylfumarat (ausschl 240mg, N3), ATC L04AX07 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerung 1x12 Mon)
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- 089PHARM GmbH, Abdi Farma GmbH, betapharm Arzneimittel GmbH, Glenmark Arzneimittel GmbH, HEXAL AG, ratiopharm GmbH, Zentiva Pharma GmbH
- Contract value
- no value published
- Bids received
- 12
- Published
- 5 Aug 2026
- Awarded
- 1 Oct 2025
- Contract start
- 1 Oct 2025
- Contract end
- 14 Oct 2026estimated
- Region
- Hamburg